KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Income from Non-Controlling Interests (2016 - 2026)

Bristol Myers Squibb has reported Income from Non-Controlling Interests over the past 18 years, most recently at $1.0 million for Q1 2026.

  • Quarterly Income from Non-Controlling Interests fell 83.33% to $1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Mar 2026, down 122.22% year-over-year, with the annual reading at $2.0 million for FY2025, 86.67% down from the prior year.
  • Income from Non-Controlling Interests was $1.0 million for Q1 2026 at Bristol Myers Squibb, up from -$1.0 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $8.0 million in Q2 2022 and troughed at -$6.0 million in Q3 2025.
  • The 5-year median for Income from Non-Controlling Interests is $4.0 million (2023), against an average of $3.1 million.
  • Year-over-year, Income from Non-Controlling Interests skyrocketed 200.0% in 2023 and then tumbled 250.0% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $3.0 million in 2022, then skyrocketed by 100.0% to $6.0 million in 2023, then tumbled by 33.33% to $4.0 million in 2024, then tumbled by 125.0% to -$1.0 million in 2025, then skyrocketed by 200.0% to $1.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Income from Non-Controlling Interests are $1.0 million (Q1 2026), -$1.0 million (Q4 2025), and -$6.0 million (Q3 2025).